Katz Steven C 4
4 · TriSalus Life Sciences, Inc. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Katz Steven C
Chief Medical Officer
Transactions
- Award
Common Stock
2024-02-12+34,144→ 68,587 total - Award
Employee Stock Option (right to buy)
2024-02-12+105,000→ 105,000 totalExercise: $9.50Exp: 2034-02-11→ Common Stock (105,000 underlying)
Footnotes (2)
- [F1]Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- [F2]One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.